Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

Science

Volumn 275, Issue 5302, 1997, Pages 960-963

  Giordano, Carla ^a   Stassi, Giorgio ^a   De Maria, Ruggero ^b   Todaro, Matilde ^a   Richiusa, Pierina ^a   Papoff, Giuliana ^c   Ruberti, Giovina ^c   Bagnasco, Marcello ^d   Testi, Roberto ^b   Galluzzo, Aldo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; FAS ANTIGEN; INTERLEUKIN 1BETA; LIGAND; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL DESTRUCTION; CONTROLLED STUDY; CROSS LINKING; FLOW CYTOMETRY; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; THYROID CELL;

EID: 0031034933     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5302.960     Document Type: Article

References (29)

1. S. Nagata and P. Golstein, Science 267, 1449 (1995); P. H. Krammer et al., Immunol. Rev. 142, 175 (1994); K. Schulze-Osthoff, Trends Cell Biol. 4, 421 (1994).
2. S. Nagata and P. Golstein, Science 267, 1449 (1995); P. H. Krammer et al., Immunol. Rev. 142, 175 (1994); K. Schulze-Osthoff, Trends Cell Biol. 4, 421 (1994).
3. S. Nagata and P. Golstein, Science 267, 1449 (1995); P. H. Krammer et al., Immunol. Rev. 142, 175 (1994); K. Schulze-Osthoff, Trends Cell Biol. 4, 421 (1994).
4. J. Coclet, F. Foureau, P. Ketelbant, P. Galand, J. E. Dumont, Clin. Endocrinol. 31, 655 (1989); J. E. Dumont, F. Lamy, P. Roger, C. Maenhout, Physiol Rev. 72, 667 (1992).
5. J. Coclet, F. Foureau, P. Ketelbant, P. Galand, J. E. Dumont, Clin. Endocrinol. 31, 655 (1989); J. E. Dumont, F. Lamy, P. Roger, C. Maenhout, Physiol Rev. 72, 667 (1992).
6. S. Dremier et al. Biochem. Biophys. Res. Commun. 200, 52 (1994).
7. T. Kotani et al. Autoimmunity 20, 231 (1995).
8. B. R. Champion, A. Cooke, D. C. Rayner, Curr. Opin. Immunol. 4, 770 (1992); A. P. Weetman and A. M. McGregor, Endocr. Rev. 15, 788 (1994).
9. B. R. Champion, A. Cooke, D. C. Rayner, Curr. Opin. Immunol. 4, 770 (1992); A. P. Weetman and A. M. McGregor, Endocr. Rev. 15, 788 (1994).
10. F. Leithauser et al., Lab. Invest. 69, 415 (1993).
11. 2 flasks in complete medium (RPMI 1640 supplemented with 10% fetal calf serum and glutamine). After overnight adhesion, unattached cells were discarded, whereas thyrocytes were removed from the flasks with 0.05% (w/v) trypsin. These cell preparations underwent a second digestion with dispase to obtain single-cell suspensions. Thyrocytes were then labeled with human serum containing anti-TPO, followed by labeling with fluorescein isothiocyanate-coupled goat anti-human Ig. Cells were then incubated for 10 min with 6% normal mouse serum before staining with phycoerithrin-conjugated UB2 mAb. Relative fluorescent intensities of individual cells were analyzed with a FACScan flow cytometer (Becton Dickinson).
12. B. Grubeck-Loebenstein et al., Clin. Exp. Immunol. 77, 324 (1989).
13. R. De Maria et al. J. Clin. Invest. 97, 1 (1996).
14. Fas-or CK-labeled cryostat thyroid sections (5 μm) were fixed in paraformaldehyde, permeabilized with 0.1% Triton X-100, and labeled by an in situ apoptosis detection kit (in situ cell death detection, alkaline phosphatase; Boehringer GmbH, Mannheim, Germany). Detection of labeled ends was done with anti-fluorescein, Fab fragment, conjugated with alkaline phosphatase. 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) (Dakopatts) was used as substrate. Sections were then counterstained with hematoxylin.
15. J. Dhein, H. Walczak, C. Baumler, K.-M. Debatin, P. H. Krammer, Nature 373, 438 (1995); T. Brunner et al., ibid., p. 441.
16. J. Dhein, H. Walczak, C. Baumler, K.-M. Debatin, P. H. Krammer, Nature 373, 438 (1995); T. Brunner et al., ibid., p. 441.
17. D. Bellgrau et al., ibid. 377, 630 (1995); T. S. Griffith, T. Brunner, S. M. Fletcher, D. R., Green, T. A. Ferguson, Science 270, 1189 (1995); L. A. French et al., J. Cell Biol. 133, 335 (1996).
18. D. Bellgrau et al., ibid. 377, 630 (1995); T. S. Griffith, T. Brunner, S. M. Fletcher, D. R., Green, T. A. Ferguson, Science 270, 1189 (1995); L. A. French et al., J. Cell Biol. 133, 335 (1996).
19. D. Bellgrau et al., ibid. 377, 630 (1995); T. S. Griffith, T. Brunner, S. M. Fletcher, D. R., Green, T. A. Ferguson, Science 270, 1189 (1995); L. A. French et al., J. Cell Biol. 133, 335 (1996).
20. P. R. Galle et al., J. Exp. Med. 182, 1223 (1995).
21. Sections were allowed to equilibrate to room temperature and were exposed to hydrogen peroxide methanol solution for 5 min. Then slides were rinsed with distilled water and placed for 5 min in a tris buffer before staining with peroxidase-antiperoxidase. Control sections were exposed with control purified rabbit IgG. Anti-FasL (C-20, rabbit polyclonal IgG) was from Santa Cruz Biotechnology (Santa Cruz, CA). For flow cytometric analysis, freshly purified thyrocytes were treated with C-20 or control rabbit IgG, followed by phycoerithrin-conjugated goat anti-rabbit IgG (Sigma), as secondary reagent.
22. + cells were then removed after 30 min binding to sheep anti-mouse IgG-coupled beads (Dynal, Wirral Merseyside, UK) and magnetic depletion.
23. C. Giordano et al., data not shown.
24. M.G. Cifone et al., EMBO J. 14, 5859 (1995); I. Cascino, G. Papoff, R. De Maria, R. Testi, G. Ruberti, J. Immunol. 156, 13 (1996).
25. M.G. Cifone et al., EMBO J. 14, 5859 (1995); I. Cascino, G. Papoff, R. De Maria, R. Testi, G. Ruberti, J. Immunol. 156, 13 (1996).
26. W. C. Liles, P. A. Kiener, J. A. Ledbetter, A. Aruffo, S. J. Klebanoff, J. Exp. Med. 184, 429 (1996). Target cells were incubated overnight with 1 μM 3,3′-dioctadecyloxacarbocyanine and exposed for 6 hours to various amounts of purified thyrocytes. Then target lysis was measured by flow cytometric analysis with the LIVE/ DEAD, cell-mediated cytotoxicity kit (Molecular Probes).
27. T. F. Davies et al., J. Clin. Invest. 89, 157 (1992).
28. Z. Wu, E. R. Podack, J. M. McKenzie, K. J. Olsen, M. Zakarija, Clin. Exp. Immunol. 98, 470 (1994).
29. Supported by Associazone Italiana Ricerca sul Cancro, Telethon, Consiglio Nazionale delle Ricerche, and the European Commission. We thank P. Bazan and G. Di Pace (Department of Surgery, University of Palermo) for surgical specimens and Genzyme Diagnostic (Cambridge, UK) for IL-1.